The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of Chylomicrons
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
GPIHBP1 anchors LPL to the capillary wall during lipolysis of lipoproteins.
“GPIHBP1 also anchors LPL to the capillary wall during lipolysis of lipoproteins (8, 9).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [8]
GPIHBP1-deficient mice exhibit severe hypertriglyceridemia and have very little LPL-mediated triglyceride uptake.
“For example, GPIHBP1-deficient mice exhibit severe hypertriglyceridemia and have very little LPL-mediated triglyceride uptake (8).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Flagged first, then by citations
Research works printed but not linked: 42
- Beckstead, 2003, Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis, Biochemistry, 42, 9416, 10.1021/bi034509t · DOI
- Bengtsson, 1979, Apolipoprotein CII enhances hydrolysis of monoglycerides by lipoprotein lipase, but the effect is abolished by fatty acids, FEBS Lett., 106, 345, 10.1016/0014-5793(79)80529-3 · DOI
- Bensadoun, 1999, Large-scale lipoprotein lipase purification from adipose tissue, Methods Mol. Biol., 109, 145
- Blaner, 1994, Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells, J. Biol. Chem., 269, 16559, 10.1016/S0021-9258(19)89425-5 · DOI
- Breckenridge, 1978, Hypertriglyceridemia associated with deficiency of apolipoprotein C-II, N. Engl. J. Med., 298, 1265, 10.1056/NEJM197806082982301 · DOI
- Burger, 1997, Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 14, 321, 10.1097/00042560-199704010-00003 · DOI
- Calandra, 2006, APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency, Curr. Opin. Lipidol., 17, 122, 10.1097/01.mol.0000217892.00618.54 · DOI
- Cardin, 1984, Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100, Thromb. Res., 34, 541, 10.1016/0049-3848(84)90258-5 · DOI
- Cardin, 1986, Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains, Biochem. Biophys. Res. Commun., 134, 783, 10.1016/S0006-291X(86)80489-2 · DOI
- Cardin, 1989, Interaction of glycosaminoglycans with lipoproteins, Ann. N Y Acad. Sci., 556, 186, 10.1111/j.1749-6632.1989.tb22503.x · DOI
- Cheng, 1981, Binding of lipoprotein lipase to endothelial cells in culture, J. Biol. Chem., 256, 12893, 10.1016/S0021-9258(18)42980-8 · DOI
- Cisar, 1989, Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation, J. Biol. Chem., 264, 1767, 10.1016/S0021-9258(18)94253-5 · DOI
- Cole, 1988, An improved method for separation of triglyceride-rich lipoproteins by FPLC, FPLC BioCommuniqué, 4, 4
- Cunningham, 2003, Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions, EMBO J., 22, 5994, 10.1093/emboj/cdg588 · DOI
- Esko, 1991, Genetic analysis of proteoglycan structure, function and metabolism, Curr. Opin. Cell Biol., 3, 805, 10.1016/0955-0674(91)90054-3 · DOI
- Goldberg, 1996, Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis, J. Lipid Res., 37, 693, 10.1016/S0022-2275(20)37569-6 · DOI
- Greenwalt, 1995, Heart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet, J. Clin. Invest., 96, 1382, 10.1172/JCI118173 · DOI
- Grosskopf, 2005, Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants, Arterioscler. Thromb. Vasc. Biol., 25, 2573, 10.1161/01.ATV.0000186189.26141.12 · DOI
- Hamilton, 1980, Unilamellar liposomes made with the French pressure cell: A simple preparative and semiquantitative technique, J. Lipid Res., 21, 981, 10.1016/S0022-2275(20)34758-1 · DOI
- Hirano, 1996, Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48, J. Biol. Chem., 271, 9887, 10.1074/jbc.271.17.9887 · DOI
- Hocquette, 1998, Lipoprotein lipase activity and mRNA levels in bovine tissues, Comp. Biochem. Physiol. B Biochem. Mol. Biol., 121, 201, 10.1016/S0305-0491(98)10090-1 · DOI
- Ioka, 2003, Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1, J. Biol. Chem., 278, 7344, 10.1074/jbc.M211932200 · DOI
- Kingsley, 1984, Receptor-mediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity, Proc. Natl. Acad. Sci. USA, 81, 5454, 10.1073/pnas.81.17.5454 · DOI
- Korn, 1955, Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart, J. Biol. Chem., 215, 1, 10.1016/S0021-9258(18)66011-9 · DOI
- Langner, 1989, The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities, J. Biol. Chem., 264, 7994, 10.1016/S0021-9258(18)83141-6 · DOI
- Lithell, 1978, Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states, Atherosclerosis, 30, 89, 10.1016/0021-9150(78)90155-7 · DOI
- Lookene, 2005, Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism, J. Biol. Chem., 280, 25383, 10.1074/jbc.M501589200 · DOI
- Lugemwa, 1991, Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis, J. Biol. Chem., 266, 6674, 10.1016/S0021-9258(20)89549-0 · DOI
- Mills, 1992, Maternal vitamin levels during pregnancies producing infants with neural tube defects, J. Pediatr., 120, 863, 10.1016/S0022-3476(05)81951-1 · DOI
- Nestel, 1962, Sites of initial removal of chylomicron triglyceride fatty acids from the blood, J. Clin. Invest., 41, 1915, 10.1172/JCI104648 · DOI
- Nguyen, 2006, A mouse monoclonal antibody specific for mouse apoB48 and apoB100 produced by immunizing “apoB39-only” mice with mouse apoB48, Biochim. Biophys. Acta, 1761, 182, 10.1016/j.bbalip.2006.02.004 · DOI
- Parthasarathy, 1994, Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase, J. Biol. Chem., 269, 22391, 10.1016/S0021-9258(17)31802-1 · DOI · Paper page
- Peirson, 2003, Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis, Nucleic Acids Res., 31, e73, 10.1093/nar/gng073 · DOI
- Pennacchio, 2001, An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing, Science, 294, 169, 10.1126/science.1064852 · DOI · Paper page
- Redlich, 1996, Characterization of carotenoid, vitamin A, and alpha-tocopheral levels in human lung tissue and pulmonary macrophages, Am. J. Respir. Crit. Care Med., 154, 1436, 10.1164/ajrccm.154.5.8912761 · DOI
- Sendak, 1998, Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis, J. Lipid Res., 39, 1310, 10.1016/S0022-2275(20)32557-8 · DOI
- Shimada, 1981, Involvement of cell surface heparin sulfate in the binding of lipoprotein lipase to cultured bovine endothelial cells, J. Clin. Invest., 68, 995, 10.1172/JCI110354 · DOI
- Strauss, 2001, Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice, J. Biol. Chem., 276, 36083, 10.1074/jbc.M104430200 · DOI
- Teng, 1992, Evolution of intestinal apolipoprotein B mRNA editing. Chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s), J. Biol. Chem., 267, 21265, 10.1016/S0021-9258(19)36827-9 · DOI
- Varma, 1998, GPI-anchored proteins are organized in submicron domains at the cell surface, Nature, 394, 798, 10.1038/29563 · DOI · Paper page
- Walzem, 1994, Overfeeding increases very low density lipoprotein diameter and causes the appearance of a unique lipoprotein particle in association with failed yolk deposition, J. Lipid Res., 35, 1354, 10.1016/S0022-2275(20)40077-X · DOI
- Weinstock, 1995, Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes, J. Clin. Invest., 96, 2555, 10.1172/JCI118319 · DOI · Paper page
Cited by
Sorted by citations
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Capillary cell-type specialization in the alveolus
Gillich, A., Zhang, F., Farmer, C. G., Travaglini, K. J., Tan, S. Y., Gu, M., Zhou, B., Feinstein, J. A., Krasnow, M. A., & Metzger, R. J. (2020) · Nature · doi:10.1038/s41586-020-2822-7 · Cited by 490
Plasma lipoproteins: genetic influences and clinical implications
Hegele, R. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2481 · Cited by 462
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315
Wang, Y., Quagliarini, F., Gusarova, V., Gromada, J., Valenzuela, D. M., Cohen, J. C., & Hobbs, H. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315292110 · Cited by 317
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
Villaret, A., Galitzky, J., Decaunes, P., Estève, D., Marques, M.-A., Sengenès, C., Chiotasso, P., Tchkonia, T., Lafontan, M., Kirkland, J. L., et al. (2010) · Diabetes · doi:10.2337/db10-0398 · Cited by 282
Wolska, A., Dunbar, R. L., Freeman, L. A., Ueda, M., Amar, M. J., Sviridov, D. O., & Remaley, A. T. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.025 · Cited by 231
Lipoprotein lipase and its regulators: an unfolding story
Wu, S. A., Kersten, S., & Qi, L. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.11.005 · Cited by 225
Stanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., & Esko, J. D. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38251 · Cited by 226
How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?
Welty, F. K. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0400-4 · Cited by 221
Targeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Self-citationHypertriglyceridemia in the genomic era: a new paradigm
Lewis, G. F., Xiao, C., & Hegele, R. A. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1062 · Cited by 152
Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells
Upadhyay, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00819 · Cited by 143
Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.
Olivecrona, G., Ehrenborg, E., Semb, H., Makoveichuk, E., Lindberg, A., Hayden, M. R., Gin, P., Davies, B. S. J., Weinstein, M. M., Fong, L. G., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002717 · Cited by 118
Self-citationJanssen, A. W. F., Katiraei, S., Bartosinska, B., Eberhard, D., Willems van Dijk, K., & Kersten, S. (2018) · Diabetologia · doi:10.1007/s00125-018-4583-5 · Cited by 96
Triglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0745-6 · Cited by 90
Angiopoietin-like Protein 4 Inhibition of Lipoprotein Lipase
Lafferty, M. J., Bradford, K. C., Erie, D. A., & Neher, S. B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497602 · Cited by 88
Angiopoietin-like 4 directs uptake of dietary fat away from adipose during fasting
Cushing, E. M., Chi, X., Sylvers, K. L., Shetty, S. K., Potthoff, M. J., & Davies, B. S. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.007 · Cited by 88
Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion
Mattijssen, F., Alex, S., Swarts, H. J., Groen, A. K., van Schothorst, E. M., & Kersten, S. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.004 · Cited by 88
The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.
Gin, P., Yin, L., Davies, B. S. J., Weinstein, M. M., Ryan, R. O., Bensadoun, A., Fong, L. G., Young, S. G., & Beigneux, A. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802579200 · Cited by 85
Self-citationChylomicronemia elicits atherosclerosis in mice—brief report.
Weinstein, M. M., Yin, L., Tu, Y., Wang, X., Wu, X., Castellani, L. W., Walzem, R. L., Lusis, A. J., Fong, L. G., Beigneux, A. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.196329 · Cited by 71
Self-citationEndothelium as a gatekeeper of fatty acid transport
Mehrotra, D., Wu, J., Papangeli, I., & Chun, H. J. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.11.001 · Cited by 60
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
Ramms, B., Patel, S., Nora, C., Pessentheiner, A. R., Chang, M. W., Green, C. R., Golden, G. J., Secrest, P., Krauss, R. M., Metallo, C. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m093740 · Cited by 59
Ahmad, Z., & Wilson, D. P. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.08.010 · Cited by 43
Young, S., Veniant, M., Beigneux, A., Bensadoun, A., & Fong, L. (2008) · Current Drug Targets · doi:10.2174/138945008783755629 · Cited by 33
Self-citationApolipoprotein A-V gene therapy for disease prevention/treatment: a critical analysis
Trudy, M., Vineeta, S., & Robert, O. (2016) · The Journal of Biomedical Research · doi:10.7555/jbr.30.20150059 · Cited by 18
A 1-month-old infant with chylomicronemia due to GPIHBP1 gene mutation treated by plasmapheresis
Jung, M. K., Jin, J., Kim, H. O., Kwon, A., Chae, H. W., Kang, S. J., Kim, D. H., & Kim, H.-S. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.1.68 · Cited by 14
Metadata
- Authors
- Beigneux, A. P., Davies, B. S. J., Gin, P., Weinstein, M. M., Farber, E., Qiao, X., Peale, F., Bunting, S., Walzem, R. L., Wong, J. S., Blaner, W. S., Ding, Z.-M., Melford, K., Wongsiriroj, N., Shu, X., de Sauvage, F., Ryan, R. O., Fong, L. G., Bensadoun, A., & Young, S. G.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 5
- Issue
- 4
- Pages
- 279-291
- ISSN
- 1550-4131
- Cited by
- 445
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review